0001159036 1 2025-11-18 2025-11-18 0001159036 2025-11-18 2025-11-18 shares iso4217:USD pure 0001159036 HALOZYME THERAPEUTICS, INC S-8 S-8 EX-FILING FEES N/A 219336 12.73 2792147.28 Equity false Common Stock, $0.001 parvalue per share true 219336 12.73 2792147.28 0.00013810 385.60 2792147.28 385.60 0 385.60 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1)         Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers an indeterminate number of additional shares of common, par value $0.001 per share (“Common Stock”), of Halozyme Therapeutics, Inc. (the “Company”), which may be offered and issued to prevent dilution resulting from stock splits, stock distributions or similar transactions.</span></div>(2)         Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and (h) under the Securities Act, based upon the weighted average option exercise price of $12.73 for 219,336 shares of Common Stock issuable upon exercise options granted under the Elektrofi, Inc. 2015 Equity Incentive Plan, which options converted into options to purchase shares of Common Stock pursuant to the Merger Agreement.